Cargando…

Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy

BACKGROUND: Focal segmental glomerular sclerosis (FSGS) is a histologic lesion rather than a specific disease entity and represents a cluster of different conditions affecting both children and adults that includes primary, secondary and genetically mediated forms. These forms can be distinguished b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roccatello, Dario, Baffa, Alessandra, Naretto, Carla, Barreca, Antonella, Cravero, Raffaella, Roscini, Elisabetta, Sciascia, Savino, Fenoglio, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387391/ https://www.ncbi.nlm.nih.gov/pubmed/37529640 http://dx.doi.org/10.1093/ckj/sfac207

Ejemplares similares

Renal involvement as a unique manifestation of hemophagocytic syndrome
por: Roccatello, Dario, et al.
Publicado: (2022)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
por: Roccatello, Dario, et al.
Publicado: (2022)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions
por: Roccatello, Dario, et al.
Publicado: (2022)

Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab
por: Fenoglio, Roberta, et al.
Publicado: (2022)

A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
por: Roccatello, Dario, et al.
Publicado: (2021)

Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
por: Roccatello, Dario, et al.
Publicado: (2020)

The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy
por: Roccatello, Dario, et al.
Publicado: (2023)

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement
por: Quattrocchio, Giacomo, et al.
Publicado: (2020)

The need for kidney biopsy in the management of side effects of target and immunotherapy
por: Fenoglio, Roberta, et al.
Publicado: (2023)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease
por: Sciascia, Savino, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Diverse Alterations of Glomerular Capillary Networks in Focal Segmental Glomerular Sclerosis
por: Morita, Megumi, et al.
Publicado: (2022)

Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
por: Fenoglio, Roberta, et al.
Publicado: (2022)

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort
por: Roccatello, Dario, et al.
Publicado: (2017)

The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult
por: Tedesco, Martina, et al.
Publicado: (2022)

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents
por: Roccatello, Dario, et al.
Publicado: (2017)

Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
por: Angeletti, Andrea, et al.
Publicado: (2021)

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
por: Sciascia, Savino, et al.
Publicado: (2023)

A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response
por: Rossi, Daniela, et al.
Publicado: (2021)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
por: Sciascia, Savino, et al.
Publicado: (2022)

Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis
por: Taneda, Sekiko, et al.
Publicado: (2011)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient
por: Al-Jehani, Mariann H., et al.
Publicado: (2021)

Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes
por: Rood, Ilse M., et al.
Publicado: (2021)

Glomerular capillary C3 deposition as a risk factor for unfavorable renal outcome in pediatric primary focal segmental glomerular sclerosis
por: Peng, Yingchao, et al.
Publicado: (2023)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It “Idiopathic”?
por: Radin, Massimo, et al.
Publicado: (2018)

Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder
Publicado: (1994)

CASK, the Soluble Glomerular Permeability Factor, Is Secreted by Macrophages in Patients With Recurrent Focal and Segmental Glomerulo—Sclerosis
por: Zhang, Xiaomeng, et al.
Publicado: (2020)

Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy
por: Yu, Fang, et al.
Publicado: (2021)

Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis
por: Lin, Li, et al.
Publicado: (2021)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2022)

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen
por: Quattrocchio, Giacomo, et al.
Publicado: (2020)

A Case Report of Adrenocorticotropic Hormone to Treat Recurrent Focal Segmental Glomerular Sclerosis Post-Transplantation and Biomarker Monitoring
por: Anwar, Siddiq, et al.
Publicado: (2015)

Recent advances in the management of systemic lupus erythematosus
por: Sciascia, Savino, et al.
Publicado: (2018)

NOTCH2NLC-related oculopharyngodistal myopathy type 3 complicated with focal segmental glomerular sclerosis: a case report
por: Ji, Guang, et al.
Publicado: (2022)

Association Between NPHS2 p.R229Q and Focal Segmental Glomerular Sclerosis/Steroid-Resistant Nephrotic Syndrome
por: Zhou, Qiongxiu, et al.
Publicado: (2022)

IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy
por: Quattrocchio, Giacomo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_boml1scr2dbg58botqpkbsci72